CVS
CVS Health Corporation (CVS) Stock Valuation
Review CVS Health Corporation (CVS) valuation with server-rendered company data, supporting context and links to related investor research.
- Price to earnings
- 24.71
- Price to book
- 1.34
- Dividend yield
- 0%
- Return on equity
- 0%
- BTI fair market cap
- $374.57B
- Premium or discount
- -67.31%
- Market cap
- $122.46B
CVS Health Corporation (CVS) Stock Valuation research
The CVS Health Corporation valuation page presents the available multiples, profitability measures and BTI fair-value context for CVS. Valuation should be compared with the company's growth, margins, balance sheet and relevant peers rather than judged by one multiple.
A premium may reflect stronger expected growth or quality, while a discount can reflect risk or weak expectations. Neither condition alone establishes that a stock is attractive or unattractive.